Moderna ETFs Rallying on COVID-19 Vaccine News to Combat Omicron

Mohit Chouhan December 01, 2021
Moderna has been rallying amid concerns surrounding the omicron variant, which has led to possibilities of a rise in demand for COVID-19 vaccines and boosters.


Post a Comment

0 Comments